Hollywood, FLNCT06972056Now EnrollingIRB Ready

Migraine Clinical Trial in Hollywood, FL

Access cutting-edge migraine treatment through this phase 4 clinical trial at a research site in Hollywood. Study-provided care at no cost to qualified participants.

Sponsored by Mayo Clinic

Quick Self-Assessment

See if you qualify for this Hollywood location

Preparing your pre-screening questions…

Expert Care in Hollywood

Access migraine specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related migraine treatment provided free

Apply for This Hollywood Location

Check if you qualify for this migraine clinical trial in Hollywood, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Hollywood

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Hollywood site if eligible
  4. 4Begin participation

About This Migraine Study in Hollywood

This goal of this study is to compare three medications used for migraine preventive treatment. This study will compare atogepant, a newer migraine preventive medication, with two older preventive medications, topiramate and propranolol. It will be determined if one works better and is more tolerable than the others. Research participants will: * Be randomly assigned to one of the three medications. * Provide information about their migraine pattern using a daily headache diary and during res

Sponsor: Mayo Clinic

Who Can Participate

Inclusion Criteria

Adults, 18-70 years of age at the time of enrollment
Migraine with aura, migraine without aura, and/or chronic migraine; according to ICHD-3 diagnostic criteria. (Those with daily or continuous headaches are not excluded.)
Migraine onset prior to 50 years of age
Migraine present for at least 12 months at the time of enrollment
At least four "moderate to severe headache days" per month (by patient self-report and then confirmed during four-week pre-randomization headache diary phase) A "moderate to severe headache day" is defined as a day during which there is a headache of moderate to severe intensity that lasts for at least four hours, or a day on which a migraine-specific acute medication is taken to treat headache.
If already taking a migraine preventive treatment, willing to continue with that treatment without dose change during the first 16 weeks of the study, including the 4-week run-in phase and 12-week randomized phase.
Not pregnant or breastfeeding
Women of childbearing potential must agree to use effective methods of contraception to reduce the risk of pregnancy.
Willingness and ability to provide informed consent.
Willingness and ability to complete all research visits.

Exclusion Criteria

Contraindications to taking atogepant, propranolol, or topiramate.
Currently taking atogepant, propranolol, or topiramate\
Previously took atogepant, propranolol, or topiramate\
Unwillingness to take atogepant, topiramate, or propranolol.
Current use of a CGRP-targeting preventive medication or beta-blocker
Migraine with brainstem aura
Hemiplegic migraine
Retinal migraine
Migraine aura without headache (exclusively)
Pure menstrual migraine
Trigeminal autonomic cephalalgias
Facial neuralgias
Secondary headache disorders (medication overuse headache is not an exclusion)
Migraine preventive treatment has been started or dose has been changed within 12 weeks prior to potential enrollment.
Used opioids or butalbital on five or more days per month on average for at least 3 months prior to enrollment.
Current or past epilepsy
Severe hepatic impairment
Moderate or more severe renal impairment \
Occasional as needed use of propranolol, currently or in the past, is not an exclusion, such as taking as needed propranolol for treatment of anxiety.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Hollywood?

Yes, this clinical trial (NCT06972056) has an active research site in Hollywood, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Migraine Treatment Options in Hollywood, FL

If you're searching for migraine treatment options in Hollywood, FL, this clinical trial (NCT06972056) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Hollywood research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced migraine specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all migraine clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Hollywood, FL

See all heart attack clinical trials recruiting in Hollywood — not just this study.

Browse Heart Attack Trials in Hollywood →

Ready to Join in Hollywood?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Hollywood, FL